e-Article
Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinib
Document Type
Academic Journal
Source
Clinical Case Reports. January 2024, Vol. 12 Issue 1
Subject
Language
English
Abstract
CASE PRESENTATION Here, we present a 49‐year‐old female patient with a history of Crohn's disease (CD) and axial spondyloarthritis, who developed symptoms of myopathy 1 week after dose increase with [...]
Key Clinical Message: We present a Crohn's disease patient receiving high dose upadacitinib treatment with elevated CPK levels and myopathy, and provide the reader with practical tips on stopping and restarting upadacitinib, emphasizing the need for adequate monitoring.
Key Clinical Message: We present a Crohn's disease patient receiving high dose upadacitinib treatment with elevated CPK levels and myopathy, and provide the reader with practical tips on stopping and restarting upadacitinib, emphasizing the need for adequate monitoring.